We are live on ! Find out more
BMGL

Basel Medical
BMGL

4 hedge funds and large institutions have $32.2K invested in Basel Medical in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.48% less ownership

Funds ownership: 0.76% → 0.29% (-0.48%)

54% less capital invested

Capital invested by funds: $70.2K → $32.2K (-$38K)

56% less funds holding

Funds holding: 9 → 4 (-5)

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
4
Holders Change
-5
Holders Change %
-55.56%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TC
T3 Companies
New York
+$9.89K
2
UBS Group
UBS Group
Switzerland
+$3.27K

Top Sellers

Rank Fund Capital Flow
1
GSC
Ground Swell Capital
South Carolina
-$16.5K
2
Citadel Advisors
Citadel Advisors
Florida
-$12.1K
3
Jane Street
Jane Street
New York
-$7.98K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$7.49K
5
Renaissance Technologies
Renaissance Technologies
New York
-$7.1K

BMGL Hedge Fund Activity: Q1 2026 in Review

4 of the 8,203 institutional investors tracked by Wall St. Rank reported a position in Basel Medical (BMGL) for Q1 2026, worth a combined $32.2K — down 54% from $70.2K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of BMGL and 1 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was T3 Companies, opening a new position worth an estimated $9.89K. The largest seller was Ground Swell Capital, exiting entirely with an estimated $16.5K sold.

  • 4 institutional investors held Basel Medical (BMGL) as of Q1 2026, down from 9 in Q4 2025.
  • Funds reported $32.2K of Basel Medical stock for Q1 2026, down 54% quarter-over-quarter.
  • 1 fund opened new Basel Medical positions in Q1 2026 and 6 closed out, a net change of -5 holders.
  • The largest Basel Medical buyer in Q1 2026 was T3 Companies, an estimated $9.89K added.
  • The largest Basel Medical seller in Q1 2026 was Ground Swell Capital, an estimated $16.5K sold.

Based on aggregated 13F filings for Q1 2026.